GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » argenx SE (NAS:ARGX) » Definitions » Price-to-Funds-From-Operations

argenx SE (argenx SE) Price-to-Funds-From-Operations : (As of Apr. 28, 2024)


View and export this data going back to 2017. Start your Free Trial

What is argenx SE Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


argenx SE (argenx SE) Business Description

Industry
Address
Laarderhoogtweg 25, Amsterdam, NH, NLD, 1101EB
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in the U.S. in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.